Trials / Conditions / Genital Neoplasms, Female

Genital Neoplasms, Female

26 registered clinical trials studyying Genital Neoplasms, Female — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations NCT07038369	Atavistik Bio, Inc	Phase 1
Not Yet Recruiting	Patient Journey in Advanced Gynecologic Cancers NCT07015593	Tongji Hospital	—
Completed	Characterization of the Intestinal and Vaginal Microbiota in Long-term Survivors of Gynecological Cancer NCT05360459	Maria Bailen Andrino	—
Active Not Recruiting	Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent NCT05051696	Liu Zi	Phase 2
Active Not Recruiting	Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cance NCT04807166	Wenjun Cheng	Phase 2
Recruiting	Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer NCT04519151	Sheba Medical Center	Phase 2
Completed	Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial NCT04679675	Kaiser Permanente	N/A
Unknown	Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian NCT04556071	Xiaoxiang Chen	Phase 2
Unknown	Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer NCT04566952	Xiaoxiang Chen	Phase 2
Unknown	Limiting Chemotherapy Side Effects by Using Moxa NCT02781155	East and North Hertfordshire NHS Trust	Phase 1 / Phase 2
Terminated	Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors NCT02499952	Nasser Hanna, M.D.	Phase 2
Completed	Effect of Early Compression and Exercise on Lymphedema Incidence in Patients With Gynecological Cancer NCT02966327	McGill University Health Centre/Research Institute of the McGill University Health Centre	N/A
Active Not Recruiting	RT for Cervical Adenocarcinoma/adenosquamous Carcinoma NCT06741046	Peking Union Medical College Hospital	—
Completed	A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer NCT01654458	Women's College Hospital	N/A
Completed	Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin NCT01074697	Odense University Hospital	Phase 3
Terminated	Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program NCT01032447	Stanford University	—
Completed	Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer NCT02609880	University of Florida	N/A
Completed	A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignanc NCT00523432	University of Chicago	Phase 1
Completed	A Trial for Patients With Advanced/Recurrent Endometrial Cancer NCT00377520	Eli Lilly and Company	Phase 2
Terminated	Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus P NCT00332280	Auron Healthcare GmbH	Phase 2 / Phase 3
Unknown	Questionnaire Study for Gynecological Cancer Survivors NCT00391664	U.S. Army Medical Research and Development Command	—
Completed	Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies NCT02182245	Boehringer Ingelheim	Phase 1
Completed	A Trial for Patients With Advanced/Recurrent Cervical Cancer NCT00190983	Eli Lilly and Company	Phase 2
Completed	An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemot NCT00191646	Eli Lilly and Company	Phase 3
Completed	Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy NCT00121030	Amgen	Phase 2
Completed	A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. NCT00191607	Eli Lilly and Company	Phase 3